open access

Vol 81, No 7 (2010)
ARTICLES
Get Citation

Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony

Grażyna Michalska-Krzanowska
Ginekol Pol 2010;81(7).

open access

Vol 81, No 7 (2010)
ARTICLES

Abstract

Abstract Background: Obstetric hemorrhage is a life-threatening situation for every mother and child. NovoSeven is a recombinant, activated factor VII which may be useful in the treatment of uncontrollable hemorrhage. It accelerates hemostasis by direct activation of the factor X. Material and methods: The author presents her own experience with administration of NovoSeven at the Intensive Care Unit, Medical University Szczecin in the treatment of bleedings after standard methods failure. NovoSeven was given to patients in postpartum hemorrhage due to uterine atony, who did not present any signs of haemostatic disorders. Results: In all presented cases, bleeding symptoms abated and hemodynamic stabilization was obtained shortly after the drug administration. Conclusion: NovoSeven is a very effective agent in the treatment of postpartum hemorrhage.

Abstract

Abstract Background: Obstetric hemorrhage is a life-threatening situation for every mother and child. NovoSeven is a recombinant, activated factor VII which may be useful in the treatment of uncontrollable hemorrhage. It accelerates hemostasis by direct activation of the factor X. Material and methods: The author presents her own experience with administration of NovoSeven at the Intensive Care Unit, Medical University Szczecin in the treatment of bleedings after standard methods failure. NovoSeven was given to patients in postpartum hemorrhage due to uterine atony, who did not present any signs of haemostatic disorders. Results: In all presented cases, bleeding symptoms abated and hemodynamic stabilization was obtained shortly after the drug administration. Conclusion: NovoSeven is a very effective agent in the treatment of postpartum hemorrhage.
Get Citation

Keywords

postpartum hemorrhage, uterine atony, recombinant activated factor VII, Haemostasis

About this article
Title

Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony

Journal

Ginekologia Polska

Issue

Vol 81, No 7 (2010)

Bibliographic record

Ginekol Pol 2010;81(7).

Keywords

postpartum hemorrhage
uterine atony
recombinant activated factor VII
Haemostasis

Authors

Grażyna Michalska-Krzanowska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl